• Mon, August 7, 2023
Michael Ulz Reiterated (ALVR) at Buy and Held Target at $20 on, Aug 7th, 2023
Michael Ulz of Morgan Stanley, Reiterated "AlloVir, Inc." (ALVR) at Buy and Held Target at $20 on, Aug 7th, 2023.
Michael has made no other calls on ALVR in the last 4 months.
There is 1 other peer that has a rating on ALVR. Out of the 1 peers that are also analyzing ALVR, 0 agree with Michael's Rating of Hold.
This is the rating of the analyst that currently disagrees with Michael
- Mani Foroohar of "SVB Securities" Maintained at Buy with Increased Target to $19 on, Wednesday, April 26th, 2023